Wiltshire4: sample sizes

Number of animals tested for each measure in this project, by strain and sex.       Cells with N < 5 are colored pink.


More info about these strains
Wiltshire4 measure Sex 129S1/SvImJ 129X1/SvJ A/J AKR/J BALB/cByJ BTBR T<+> Itpr3<tf>/J BUB/BnJ C3H/HeJ C57BL/6J C57BLKS/J C57BR/cdJ C58/J CBA/J CZECHII/EiJ DBA/2J FVB/NJ I/LnJ KK/HlJ LG/J LP/J MA/MyJ NOD/ShiLtJ NON/ShiLtJ NZB/BlNJ NZO/HlLtJ NZW/LacJ PERA/EiJ PL/J PWD/PhJ PWK/PhJ RIIIS/J SEA/GnJ SJL/J SM/J SWR/J WSB/EiJ
Bcells_BEZ_ctrl   B cells, percent viability , control   52401 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_BEZ_A   B cells, percent viability , dose: 0.046 µM   52402 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_BEZ_B   B cells, percent viability , dose: 0.137 µM   52403 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_BEZ_C   B cells, percent viability , dose: 1.235 µM   52404 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_BEZ_D   B cells, percent viability , dose: 11.1 µM   52405 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_BEZ_E   B cells, percent viability , dose: 100 µM   52406 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_BEZ_ctrl   T cells, percent viability , control   52407 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_BEZ_A   T cells, percent viability , dose: 0.046 µM   52408 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_BEZ_B   T cells, percent viability , dose: 0.137 µM   52409 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_BEZ_C   T cells, percent viability , dose: 1.235 µM   52410 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_BEZ_D   T cells, percent viability , dose: 11.1 µM   52411 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_BEZ_E   T cells, percent viability , dose: 100 µM   52412 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_BEZ_ctrl   monocytes, percent viability , control   52413 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_BEZ_A   monocytes, percent viability , dose: 0.046 µM   52414 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_BEZ_B   monocytes, percent viability , dose: 0.137 µM   52415 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_BEZ_C   monocytes, percent viability , dose: 1.235 µM   52416 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_BEZ_D   monocytes, percent viability , dose: 11.1 µM   52417 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_BEZ_E   monocytes, percent viability , dose: 100 µM   52418 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Dox_ctrl   B cells, percent viability , control   52421 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Dox_A   B cells, percent viability , dose: 0.046 µM   52422 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Dox_B   B cells, percent viability , dose: 0.137 µM   52423 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Dox_C   B cells, percent viability , dose: 1.235 µM   52424 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Dox_D   B cells, percent viability , dose: 11.1 µM   52425 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Dox_E   B cells, percent viability , dose: 100 µM   52426 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 1 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Dox_ctrl   T cells, percent viability , control   52427 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Dox_A   T cells, percent viability , dose: 0.046 µM   52428 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Dox_B   T cells, percent viability , dose: 0.137 µM   52429 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Dox_C   T cells, percent viability , dose: 1.235 µM   52430 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Dox_D   T cells, percent viability , dose: 11.1 µM   52431 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Dox_E   T cells, percent viability , dose: 100 µM   52432 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 1 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Dox_ctrl   monocytes, percent viability , control   52433 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Dox_A   monocytes, percent viability , dose: 0.046 µM   52434 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Dox_B   monocytes, percent viability , dose: 0.137 µM   52435 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Dox_C   monocytes, percent viability , dose: 1.235 µM   52436 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Dox_D   monocytes, percent viability , dose: 11.1 µM   52437 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 3 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Dox_E   monocytes, percent viability , dose: 100 µM   52438 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 1 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Ida_ctrl   B cells, percent viability , control   52441 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Ida_A   B cells, percent viability , dose: 0.046 µM   52442 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Ida_B   B cells, percent viability , dose: 0.137 µM   52443 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Ida_C   B cells, percent viability , dose: 1.235 µM   52444 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Ida_D   B cells, percent viability , dose: 11.1 µM   52445 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Ida_E   B cells, percent viability , dose: 100 µM   52446 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Ida_ctrl   T cells, percent viability , control   52447 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Ida_A   T cells, percent viability , dose: 0.046 µM   52448 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Ida_B   T cells, percent viability , dose: 0.137 µM   52449 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Ida_C   T cells, percent viability , dose: 1.235 µM   52450 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Ida_D   T cells, percent viability , dose: 11.1 µM   52451 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Ida_E   T cells, percent viability , dose: 100 µM   52452 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Ida_ctrl   monocytes, percent viability , control   52453 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Ida_A   monocytes, percent viability , dose: 0.046 µM   52454 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Ida_B   monocytes, percent viability , dose: 0.137 µM   52455 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Ida_C   monocytes, percent viability , dose: 1.235 µM   52456 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Ida_D   monocytes, percent viability , dose: 11.1 µM   52457 (F)
(M) 4 4 4 4 4 3 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Ida_E   monocytes, percent viability , dose: 100 µM   52458 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Sel_ctrl   B cells, percent viability , control   52461 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Sel_A   B cells, percent viability , dose: 0.046 µM   52462 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Sel_B   B cells, percent viability , dose: 0.137 µM   52463 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Sel_C   B cells, percent viability , dose: 1.235 µM   52464 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Sel_D   B cells, percent viability , dose: 11.1 µM   52465 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Bcells_Sel_E   B cells, percent viability , dose: 100 µM   52466 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Sel_ctrl   T cells, percent viability , control   52467 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Sel_A   T cells, percent viability , dose: 0.046 µM   52468 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Sel_B   T cells, percent viability , dose: 0.137 µM   52469 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Sel_C   T cells, percent viability , dose: 1.235 µM   52470 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Sel_D   T cells, percent viability , dose: 11.1 µM   52471 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
Tcells_Sel_E   T cells, percent viability , dose: 100 µM   52472 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Sel_ctrl   monocytes, percent viability , control   52473 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Sel_A   monocytes, percent viability , dose: 0.046 µM   52474 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Sel_B   monocytes, percent viability , dose: 0.137 µM   52475 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Sel_C   monocytes, percent viability , dose: 1.235 µM   52476 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Sel_D   monocytes, percent viability , dose: 11.1 µM   52477 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3
monocytes_Sel_E   monocytes, percent viability , dose: 100 µM   52478 (F)
(M) 4 4 4 4 4 4 4 4 4 4 2 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 4 3